Blockade of Grb2 after AKI significantly attenuates cardiac damage and sustains myocardial functions through a mechanism involving the re-activation of Akt/mTOR pathway and preservation of cardiomyocyte bioenergetics. This evidence concerns the gene GRB2 and acute kidney injury.